Economic evaluation of prenatal screening for Down syndrome in the U.S.A.

Prenatal Diagnosis

Volumn 18, Issue 12, 1998, Pages 1241-1252

  Beazoglou, Tryfon ^a,d   Heffley, Dennis ^a   Kyriopoulos, John ^b   Vintzileos, Anthony ^c   Benn, Peter ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Amniocentesis; Down syndrome; Economic evaluation; Prenatal screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; AMNIOCENTESIS; ARTICLE; COST BENEFIT ANALYSIS; DOWN SYNDROME; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRENATAL SCREENING; PRIORITY JOURNAL; UNITED STATES;

ADULT; COST-BENEFIT ANALYSIS; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL AGE; MODELS, ECONOMIC; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0032406152     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199812)18:12<1241::AID-PD440>3.0.CO;2-M     Document Type: Article

References (13)

1. American College of Obstetricians and Gynecologists (1994). Down Syndrome Screening. ACOG Committee Opinion no. 141. Washington, DC: American College of Obstetricians and Gynecologists, 1-4.
2. Benn, P.A. (1998). Preliminary evidence for associations between second trimester human chorionic gonadotrophin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies, Prenat. Diagn., 18, 319-324.
3. Benn, P.A., Borgeda, A., Horne, D., Briganti, S., Collins, R., Rodis, J.F. (1997). Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography, Am. J. Obstet. Gynecol., 176, 1056-1061.
4. Benn, P.A., Home, D., Briganti, S., Greenstein, R.M. (1995). Prenatal diagnosis of diverse chromosome abnormalities in patients identified by triple marker testing as screen-positive for Down syndrome, Am. J. Obstet. Gynecol., 173, 496-501.
5. Burton, B.K. (1992). Unexplained elevated maternal serum alpha- fetoprotein and adverse perinatal out-come. In: Elias, S., Simpson, J.L. (Eds). Maternal Serum Screening for Fetal Genetic Disorders, New York: Churchill. Livingstone, 109-119.
6. Cuckle, H.S., Wald, N.J., Thompson, S.G. (1987). Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level, Br. J. Obstet. Gynaecol., 94, 387-402.
7. Cuckle, H.S., Wald, N.J. (1992). hCG, estriol, and other maternal blood markers of fetal aneuploidy. In: Elias, S., Simpson, J.L. (Eds). Maternal Serum Screening for Fetal Genetic Disorders, New York: Churchill Livingstone, 87-107.
8. Ferguson-Smith, M.A., Yates, J.R.W. (1984). Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative study on 52 965 amniqcenteses, Prenat. Diagn., (special issue), 5-44.
9. Gill, M., Murday, V., Slack, J. (1987). An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration, Soc. Sci. Med., 24, 725-731.
10. Goodburn, S.F., Yates, J.R.W., Raggatt, P.R., Carr, C., Ferguson-Smith, M.E., Kershaw, A.J., Milton, P.J.D., Ferguson-Smith, M.A. (1994). Second trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme, Prenat. Diagn., 14, 391-402.
11. Haddow, J.E., Palomaki, G.E. 1993). Prenatal screening for Down syndrome. In: Simpson, J.L., Elias, S. (Eqs). Essentials of Prenatal Diagnosis, New York: Churchill Livingstone, 185-220.
12. Haddow J.E., Palomaki G.E., Knight G.J., Cunningham G.C., Lustig L.S., Boyd P.A. (1994). Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening, NEJM, 33, 1114-1118.
13. Huang, T., Watt, H.C., Wald, N.J. (1997). The effect of differences in the distribution of maternal age in England and Wales on the performance of prenatal screening for Down syndrome, Prenat. Diagn., 17, 615-621.